loading
전일 마감가:
$1.12
열려 있는:
$1.295
하루 거래량:
9.31M
Relative Volume:
53.93
시가총액:
$81.16M
수익:
$2.91M
순이익/손실:
$-220.40M
주가수익비율:
-0.3709
EPS:
-3.64
순현금흐름:
$-176.15M
1주 성능:
+14.41%
1개월 성능:
+6.30%
6개월 성능:
-77.91%
1년 성능:
-80.12%
1일 변동 폭
Value
$1.29
$1.39
1주일 범위
Value
$1.08
$1.39
52주 변동 폭
Value
$0.92
$22.50

Igm Biosciences Inc Stock (IGMS) Company Profile

Name
명칭
Igm Biosciences Inc
Name
전화
650-965-7873
Name
주소
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Name
직원
54
Name
트위터
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
IGMS's Discussions on Twitter

IGMS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IGMS
Igm Biosciences Inc
1.35 81.16M 2.91M -220.40M -176.15M -3.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
454.79 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
544.31 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.00 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
558.74 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.00 28.51B 3.81B -644.79M -669.77M -6.24

Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-10 다운그레이드 BMO Capital Markets Outperform → Market Perform
2025-01-10 다운그레이드 Guggenheim Buy → Neutral
2025-01-10 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2025-01-10 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2025-01-10 다운그레이드 Stifel Buy → Hold
2024-12-06 개시 BMO Capital Markets Outperform
2024-10-01 다운그레이드 JP Morgan Neutral → Underweight
2024-10-01 다운그레이드 Truist Buy → Hold
2024-02-09 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2023-12-15 다운그레이드 BofA Securities Buy → Neutral
2023-12-07 다운그레이드 H.C. Wainwright Buy → Neutral
2022-11-09 재개 Jefferies Buy
2022-10-17 개시 JP Morgan Neutral
2022-08-29 개시 BofA Securities Buy
2021-12-13 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2021-11-05 업그레이드 Wedbush Neutral → Outperform
2021-08-26 개시 Morgan Stanley Overweight
2021-01-29 개시 RBC Capital Mkts Outperform
2021-01-19 재확인 H.C. Wainwright Buy
2020-12-22 다운그레이드 Wedbush Outperform → Neutral
2020-07-17 개시 Robert W. Baird Outperform
2020-07-01 개시 H.C. Wainwright Buy
2020-05-28 개시 SunTrust Buy
2020-04-22 개시 Wedbush Outperform
2019-10-14 개시 Guggenheim Buy
2019-10-14 개시 Jefferies Buy
2019-10-14 개시 Piper Jaffray Overweight
2019-10-14 개시 Stifel Buy
모두보기

Igm Biosciences Inc 주식(IGMS)의 최신 뉴스

pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 12, 2025

IGM Biosciences price target lowered to $1 from $2 at Truist - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech

Jun 12, 2025
pulisher
Jun 11, 2025

IGM Biosciences Faces Nasdaq Non-Compliance Notice - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Truist Revises IGM Biosciences (IGMS) Price Target to $1 | IGMS Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Truist Cuts Price Target on IGM Biosciences to $1 From $2, Keeps Hold Rating - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

IGM Biosciences (NASDAQ:IGMS) Cut to "Sell" at Wall Street Zen - MarketBeat

Jun 11, 2025
pulisher
Jun 09, 2025

Millennium Management LLC Sells 69,074 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Grows Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

IGM Biosciences (NASDAQ:IGMS) Rating Lowered to “Sell” at Wall Street Zen - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

IGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat

Jun 05, 2025
pulisher
Jun 03, 2025

IGM Biosciences (NASDAQ:IGMS) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Jun 03, 2025
pulisher
Jun 02, 2025

IGM Biosciences Reports Increased Net Loss Amid Strategic Focus - TipRanks

Jun 02, 2025
pulisher
Jun 01, 2025

Wall Street Zen Upgrades IGM Biosciences (NASDAQ:IGMS) to “Hold” - Defense World

Jun 01, 2025
pulisher
May 31, 2025

IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World

May 31, 2025
pulisher
May 29, 2025

IGM Biosciences Terminates Headquarters Lease Agreement - TipRanks

May 29, 2025
pulisher
May 29, 2025

IGM Biosciences, Inc. (NASDAQ:IGMS) Shares Sold by D. E. Shaw & Co. Inc. - Defense World

May 29, 2025
pulisher
May 22, 2025

IGM Biosciences earnings missed by $0.51, revenue fell short of estimates - Investing.com Canada

May 22, 2025
pulisher
May 22, 2025

Sanofi Invests $8.79 Million in IGM Biosciences, Inc. (NASDAQ:IGMS) - MarketBeat

May 22, 2025
pulisher
May 21, 2025

Rheumatoid Arthritis Market Anticipated to Expand Rapidly During 2024-2034, Says DelveInsight | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB BIOSCIENCES GmbH - The Globe and Mail

May 21, 2025
pulisher
May 20, 2025

IGM Biosciences’ SWOT analysis: biotech stock faces pivotal moment By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 20, 2025

IGM Biosciences’ SWOT analysis: biotech stock faces pivotal moment - Investing.com

May 20, 2025
pulisher
May 19, 2025

30,148 Shares in IGM Biosciences, Inc. (NASDAQ:IGMS) Bought by Cubist Systematic Strategies LLC - Defense World

May 19, 2025
pulisher
May 14, 2025

IGM Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 14, 2025
pulisher
May 13, 2025

IGM Biosciences (IGMS) to Release Earnings on Wednesday - MarketBeat

May 13, 2025
pulisher
May 13, 2025

IGM Biosciences (IGMS) to Release Quarterly Earnings on Wednesday - Defense World

May 13, 2025
pulisher
May 10, 2025

IGM Biosciences says it is dropping development of imvotamab - The Pharma Letter

May 10, 2025
pulisher
May 09, 2025

Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures - Fierce Biotech

May 09, 2025
pulisher
May 08, 2025

IGM Biosciences ends agreement with Sanofi - Investing.com Australia

May 08, 2025
pulisher
May 08, 2025

IGM Biosciences ends agreement with Sanofi By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

IGM Biosciences Ends Genzyme Collaboration, Cuts Workforce - TipRanks

May 08, 2025
pulisher
May 08, 2025

Engineering an antibody against flu with sticky staying power - Ohio State News

May 08, 2025
pulisher
May 07, 2025

Price T Rowe Associates Inc. MD Sells 445,260 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) - MarketBeat

May 07, 2025
pulisher
May 04, 2025

Renaissance Technologies LLC Raises Stock Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World

May 04, 2025
pulisher
May 03, 2025

IGM Biosciences (NASDAQ:IGMS) Stock Price Down 1.5%Here's Why - MarketBeat

May 03, 2025
pulisher
May 02, 2025

IGM Biosciences Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView

May 02, 2025

Igm Biosciences Inc (IGMS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Igm Biosciences Inc 주식 (IGMS) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Tahir Misbah
CHIEF FINANCIAL OFFICER
Jun 16 '25
Sale
1.20
1,522
1,825
178,802
Harler Mary Beth
Chief Executive Officer
Jun 16 '25
Sale
1.20
1,522
1,825
338,181
Decker Lisa Lynn
CHIEF BUSINESS OFFICER
Jun 16 '25
Sale
1.20
951
1,140
72,578
Weber Steven
PRINCIPAL ACCOUNTING OFFICER
May 14 '25
Sale
1.12
1,865
2,090
27,016
Weber Steven
PRINCIPAL ACCOUNTING OFFICER
Mar 14 '25
Sale
1.23
1,701
2,092
28,881
Tahir Misbah
CHIEF FINANCIAL OFFICER
Mar 14 '25
Sale
1.23
7,329
9,015
180,324
Harler Mary Beth
Chief Executive Officer
Mar 14 '25
Sale
1.23
7,329
9,015
339,703
Decker Lisa Lynn
CHIEF BUSINESS OFFICER
Mar 14 '25
Sale
1.23
4,512
5,550
73,529
$20.91
price up icon 1.21%
$36.18
price up icon 0.58%
$20.72
price down icon 2.91%
$99.33
price down icon 1.11%
$107.07
price up icon 0.55%
biotechnology ONC
$242.60
price up icon 0.07%
자본화:     |  볼륨(24시간):